Roche Holding AG's Fiscal Year is From January To December - All Figures are in CHF, Billions.
The item "Free-Cash-Flow-To-The-Firm" stands at 16.67 Billion Swiss Francs for the trailing twelve months (TTM) period ending 06/30/2025.'
Regarding the One-Year-Change of the series, the current value constitutes an increase of 35.36 percent compared to the value the year prior.
The 1 year change in percent is 35.36.
The 3 year change in percent is -38.76.
The 5 year change in percent is -32.47.
The 10 year change in percent is -9.49.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Free Cash Flow To The Firm | 905,699,262,464.00 |
![]() | Johnson & Johnson - Free Cash Flow To The Firm | 486,508,953,600.00 |
![]() | AbbVie Inc - Free Cash Flow To The Firm | 399,570,305,024.00 |
![]() | AstraZeneca PLC - Free Cash Flow To The Firm | 280,205,508,085.11 |
![]() | Novartis AG - Free Cash Flow To The Firm | 255,096,620,580.91 |